> Details

Meador, Catherine B.; Micheel, Christine M.; Levy, Mia A.; Lovly, Christine M.; Horn, Leora; Warner, Jeremy L.; Johnson, Douglas B.; Zhao, Zhongming; Anderson, Ingrid A.; Sosman, Jeffrey A.; Vnencak-Jones, Cindy L.; Dahlman, Kimberly B.; Pao, William

Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies
  • Contributor: Meador, Catherine B.; Micheel, Christine M.; Levy, Mia A.; Lovly, Christine M.; Horn, Leora; Warner, Jeremy L.; Johnson, Douglas B.; Zhao, Zhongming; Anderson, Ingrid A.; Sosman, Jeffrey A.; Vnencak-Jones, Cindy L.; Dahlman, Kimberly B.; Pao, William
  • imprint: American Association for Cancer Research (AACR), 2014
  • Published in: Clinical Cancer Research
  • Language: English
  • DOI: 10.1158/1078-0432.ccr-13-1591
  • ISSN: 1078-0432; 1557-3265
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title> <jats:p>Increased understanding of intertumoral heterogeneity at the genomic level has led to significant advancements in the treatment of solid tumors. Functional genomic alterations conferring sensitivity to targeted therapies can take many forms, and appropriate methods and tools are needed to detect these alterations. This review provides an update on genetic variability among solid tumors of similar histologic classification, using non–small cell lung cancer and melanoma as examples. We also discuss relevant technological platforms for discovery and diagnosis of clinically actionable variants and highlight the implications of specific genomic alterations for response to targeted therapy. Clin Cancer Res; 20(9); 2264–75. ©2014 AACR.</jats:p>
  • Access State: Open Access